Context: TSH is the major growth factor for thyrocytes and may have a causative role in
thyroid cancer. Objective: The objective of the study was to systematically assess the …

Abstract Context: Thyroglobulin autoantibodies (TgAb) are primarily measured in serum in
conjunction with thyroglobulin (Tg)—the primary tumor marker used to monitor patients with …

Objective No consensus exists on the association between papillary thyroid carcinoma
(PTC) and Hashimoto's thyroiditis (HT). To resolve this controversy, this study aimed to …

Objective Research data suggest that patients with Hashimoto's thyroiditis may increase the
risk of cancer. However, existing research is inconsistent with this view. Therefore, to …

Background: Many recent studies suggest the immune system plays a significant role in the
pathogenesis of autoimmune diseases, chronic inflammatory diseases, and cancer …

Context: TSH is the main factor involved in the control of proliferation of thyrocytes. Recently,
a strong relationship between serum TSH and risk of thyroid malignancy has been reported …

Background The incidence of thyroid cancer (TC) is increasing although explanatory causes
are lacking. A link between cancer and inflammation is well documented but unclear for …

Background: Thyroid cancer has increased globally, with a prominent increase in small,
papillary thyroid cancers (PTC). The Korean population has a high iodine intake, high …

Objective It remains inconclusive whether Hashimoto's thyroiditis (HT) predisposes patients
to the development of papillary thyroid carcinoma (PTC). We conducted a meta-analysis of …

Objective Hashimoto's thyroiditis (HT) has been associated with an elevated risk of papillary
thyroid cancer (PTC). To investigate the possible influence of HT on the prognosis of PTC …